Diurnal’s Alkindi receives approval from the Ministry of Health in Israel
LONDON: Diurnal Group plc announced that Alkindi (hydrocortisone granules in capsules for opening) has received approval from the Ministry of Health in Israel as a replacement therapy of adrenal insufficiency (AI) in infants, children and adolescents (from birth to <18…